Skip to main content
Fig. 4 | Renal Replacement Therapy

Fig. 4

From: Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

Fig. 4

Antibody titers between patients with or without fever after the second vaccination. Anti-S1 antibody titers of subjects who developed fever 2 weeks after the second vaccination were significantly elevated than those who did not in both Control group and HD group (Control group: fever: 2,460 /mL vs non-fever: 1,370 BAU/mL, p = 0.0096, HD group: fever: 1,375 /mL vs non-fever: 1,030 BAU/mL, p = 0.0383). *p < 0.05, **p < 0.01. HD, hemodialysis; BAU, binding antibody unit

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us